Literature DB >> 33395337

WHO recommends corticosteroids for patients with severe or critical COVID-19.

Holly Keyt1.   

Abstract

SOURCE CITATION: Lamontagne F, Agoritsas T, Macdonald H, et al. A living WHO guideline on drugs for covid-19. BMJ. 2020;370:m3379. 32887691.

Entities:  

Year:  2021        PMID： 33395337     DOI： 10.7326/ACPJ202101190-002

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


  4 in total

1.  Comparison of standard prophylactic, intermediate prophylactic and therapeutic anticoagulation in patients with severe COVID-19: protocol for the ANTICOVID multicentre, parallel-group, open-label, randomised controlled trial.

Authors:  Vincent Labbe; Damien Contou; Nicholas Heming; Bruno Megarbane; Hafid Ait-Oufella; Florence Boissier; Serge Carreira; Alexandre Robert; Emmanuel Vivier; Mohamed Fejjal; Denis Doyen; Mehran Monchi; Sebastien Preau; Elise Noel-Savina; Bertrand Souweine; Noémie Zucman; Santiago Alberto Picos; Martin Dres; William Juguet; Eric Mariotte; Jean-François Timsit; Matthieu Turpin; Keyvan Razazi; Ségolène Gendreau; Samia Baloul; Guillaume Voiriot; Muriel Fartoukh; Etienne Audureau; Armand Mekontso Dessap
Journal:  BMJ Open       Date:  2022-04-26       Impact factor: 3.006

2.  Efficacy Evaluation of Thymosin Alpha 1 in Non-severe Patients With COVID-19: A Retrospective Cohort Study Based on Propensity Score Matching.

Authors:  ChenLu Huang; Ling Fei; Wei Xu; WeiXia Li; XuDong Xie; Qiang Li; Liang Chen
Journal:  Front Med (Lausanne)       Date:  2021-04-23

Review 3.  Possible harm from glucocorticoid drugs misuse in the early phase of SARS-CoV-2 infection: a narrative review of the evidence.

Authors:  Riccardo Sarzani; Francesco Spannella; Federico Giulietti; Chiara Di Pentima; Piero Giordano; Andrea Giacometti
Journal:  Intern Emerg Med       Date:  2021-10-31       Impact factor: 3.397

Review 4.  New Insights on Effects of Glucocorticoids in Patients With SARS-CoV-2 Infection.

Authors:  Elena Chertok Shacham; Avraham Ishay
Journal:  Endocr Pract       Date:  2022-07-21       Impact factor: 3.701
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.